Compound ID | 90
Synonym(s): S-649266 | GSK-2696266 | RSC 649266
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-negative |
Details of activity: | Health care-associated pneumonia, bloodstream infections, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, complicated urinary tract infections |
Description: | First approved siderophore-antibiotic conjugate |
Institute where first reported: | Shionogi, Japan |
Year first mentioned: | 2013 |
Highest developmental phase: | Approved by FDA in 2019 |
Development status: | Approved |
Chemical structure(s): | |
Canonical SMILES: | CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@@H]2C(=O)N3C(=C(C[N+]4(CCCC4)CCNC(=O)C5=CC=C(C(=C5Cl)O)O)CS[C@H]23)C(=O)[O-] |
Isomeric SMILES: | CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-] |
InChI: | InChI=1S/C30H34ClN7O10S2/c1-30(2,28(46)47)48-36-19(16-13-50-29(32)34-16)24(42)35-20-25(43)37-21(27(44)45)14(12-49-26(20)37)11-38(8-3-4-9-38)10-7-33-23(41)15-5-6-17(39)22(40)18(15)31/h5-6,13,20,26H,3-4,7-12H2,1-2H3,(H7-,32,33,34,35,36,39,40,41,42,44,45,46,47)/t20-,26-/m1/s1 |
InChI Key: | DBPPRLRVDVJOCL-FQRUVTKNSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/77843966 |
External links: | |
Guide to Pharmacology: | cefiderocol |
Main Source: | https://www.shionogi.com/category/cefiderocol/ |
Citations: |
|